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Preview
mental signal, the Langmuir trough contains only oneMolecular Engineering of Peptides
lipid monolayer, which gives insufficient signal for some
important experimental methods such as NMR but,
more importantly, allows the area of a lipid film overlying
water to be controlled dynamically and studied by vari-
Deeper understanding of the role of short peptides
ous methods including fluorescence microscopy, X-ray
in lipid layers has revealed potential applications for
diffraction, and pressure-area isotherm measurements.
rationally designed synthetic replacements. A recent
The use of the Langmuir trough to measure interactions
report illustrates the succesful design of a peptoid
between lipids and lung surfactant peptides, specifically
mimic of SP-C, a protein linked to respiratory distress
a 25-amino-acid, truncated portion of the 78-residue
syndrome.
SP-B protein, was pioneered by the groups of Zasadzin-
ski and Waring [8].
Traditionally, rational drug design has primarily relied The Barron and Lee collaboration focused on SP-C,
on biomolecular physics and chemistry. However, im- a 35-residue peptide that evidently adopts a transmem-
proved technologies have illustrated the importance of brane orientation [3,9]. While the membrane-spanning
understanding the transport properties of compounds, helix of SP-C (residues 9–34) appears to be important
forging collaborations between teams that include both in maintaining peptide function, the exact residues do
chemists and engineers. An excellent example of the not appear to be critical [9], suggesting that nonpeptide
progress that can be made through such cross-disci- mimics might be viable replacements for SP-C. To this
plinary research is provided Wu and colleagues in a end, the authors chose to synthesize and study in vitro
paper published in this issue of Chemistry & Biology [1] peptoid mimics of SP-C. As Wu et al. explain, peptoids
which describes the efforts of the groups of Annelise are stable against protease degradation [10], less prone
Barron of the Chemical Engineering Department at to immune recognition than proteins, and relatively easy
Northwestern University and of Ka Yee Lee of the Univer- to synthesize [2]. While their backbone is achiral, chiral-
sity of Chicago Chemistry Department. This team en- ity and helix formation can be induced through attach-
deavors to use rational design to develop replacements ment of chiral side groups, which can also be chosen
for the natural lung surfactant proteins that are essential to mimic the side chains of natural proteins, including
for proper function of the human lung and have focused their charge, hydrophobicity, and hydrophilicity [11].
in particular on the family of “peptoids,” poly-N-substi- Peptoid versions of short arginine-rich peptides have
tuted glycines [2], as sequence-specific oligomers already been synthesized that successfully transport
whose properties can be made to mimic natural pep- proteins across membranes, as their peptide counter-
tides. parts do [12]. This discovery, combined with the obser-
Lipids, such as dipalmitoylphosphatidylcholine, are vation that at least the helical portion of SP-C is not
the major component of lung surfactant, which lowers sensitive to amino-acid sequence (as long as helicity is
the interfacial tension of the aveolar lining of the lung preserved), suggests that suitably designed peptoids
to permit breathing. However, lung surfactant also con- should be good candidates for mimicing SP-C function.
tains four different proteins, SP-A, SP-B, SP-C, and Indeed, the researchers found strong similarities be-
SP-D [3]. Two of these, SP-B and SP-C, appear to modu- tween a slightly modified SP-C peptide and a peptoid
late the fluidity of the membrane, particularly during the mimic in their effects on the physical properties of mem-
breathing cycle, and the lack of one of these proteins, branes, including surface-tension versus time in a pulsat-
SP-B, results in respiratory distress syndrome in se- ing bubble surfactometer and pressure-area isotherms
verely premature infants [4], leading to death unless and fluorescence microscopy in a Langmuir-Wilhelmy
a functional replacement is supplied. This condition is surface balance. The group now plans to carry out ani-
echoed in transgenic mice that do not express SP-B mal studies with the peptoid mimic of SP-C and to syn-
protein because the corresponding gene has been ab- thesize and study a peptoid mimic of the more complex
lated [5], and replacement therapy with surfactants con- SP-B lung surfactant peptide.
taining either SP-B or SP-C has been shown to restore In general, the most promising protein candidates for
lung function to surfactant-deficient animals [6, 7]. While mimicry are short ones, whose function does not require
lung surfactant from animals can successfully substitute precisely designed active sites. Thus, short membrane
for the missing protein, risks of contamination and im- peptides are among the most obvious choices. In addi-
munogenic reaction motivate the search for synthetic tion to membrane transporters and lung surfactant pep-
replacements for the natural proteins. tides (which meet these criteria), antimicrobial peptides
In the work of Wu et al. [1], a Langmuir-Wilhelmy come to mind. These are usually 15–45-residue pep-
surface balance is exploited as a platform for examining tides, with predominantly -helical,  sheet, or mixed
the effects of synthetic lung surfactant components on secondary structure, frequently both cationic and am-
lipid monolayer properties under conditions that to phipathic [13, 14]. They function by thinning the mem-
some extent mimic breathing. In contrast to other sys- brane or perforating it, causing leakage of electrolytes.
tems containing vesicles and multilayer stacks that con- Why these peptides work selectively on bacterial mem-
branes and not on host cell membranes is still rathertain many lipid layers, providing an abundant experi-
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